REQUEST A DEMO
Total
USD $0.00
FAQ
Secure shopping

Pharma & Healthcare

The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.

The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.

Peru Pharma and Healthcare Sector Report 2019/2020 - Page 1
Peru Pharma and Healthcare Sector Report 2019/2020 EMIS Insights Industry Reports

Peru is a comparatively small pharmaceutical market in Latin America (ranking eighth in terms of sales volume in 2017), with a relatively young and growing population. However, public health spending is expanding at a rapid pace, particularly in ...

View more details
USD 495 Date: April 2019 Language: English
Format: PDF
Add to basket
Latin America Pharma and Healthcare Sector Report 2018/2022 - Page 1
Latin America Pharma and Healthcare Sector Report 2018/2022 EMIS Insights Industry Reports

Although the global pharma & healthcare sector is dominated by large multinational companies, mainly from the developed countries, Latin America has been quickly catching up in building a domestic pharmaceutical production base and expanding the ...

View more details
USD 495 Date: March 2019 Language: English
Format: PDF
Add to basket
Mexico Pharma and Healthcare Sector Report 2019/2020 - Page 1
Mexico Pharma and Healthcare Sector Report 2019/2020 EMIS Insights Industry Reports

Mexico is the second-largest pharmaceutical market in Latin America, behind only Brazil, with a large and growing population, multiple but underfunded state-run health insurance schemes, and a small but rapidly developing private health insurance ...

View more details
USD 495 Date: February 2019 Language: English
Format: PDF
Add to basket
Brazil Pharma and Healthcare Sector Report 2018/2022 - Page 1
Brazil Pharma and Healthcare Sector Report 2018/2022 EMIS Insights Industry Reports

Brazil’s 208mn population has given rise to a sizeable healthcare sector and to the sixth largest pharmaceutical market in the world. In 2017, retail drug sales, based on pharmacy purchase price (PPP), rose by 11.7% y/y to BRL 56.8bn, supported ...

View more details
USD 995 Date: February 2019 Language: English
Format: PDF
Add to basket
Colombia Pharma and Healthcare Sector Report 2019/2020 - Page 1
Colombia Pharma and Healthcare Sector Report 2019/2020 EMIS Insights Industry Reports

Colombia is a mid-sized pharmaceutical market in Latin America (ranking fourth in terms of sales volume in 2017, after Brazil, Mexico and Argentina), with a large and growing population, a universal but underfunded social security health insurance ...

View more details
USD 495 Date: January 2019 Language: English
Format: PDF
Add to basket
Argentina Pharma and Healthcare Sector 2018/2019 - Page 1
Argentina Pharma and Healthcare Sector 2018/2019 EMIS Insights Industry Reports

Argentina is among the top 20 pharmaceutical markets globally, ranking third in Latin America, with estimated drug retail sales of USD 6.1bn in 2017. The country also features a large and ageing population, a relatively developed public health system ...

View more details
USD 495 Date: August 2018 Language: English
Format: PDF
Add to basket
Chile Pharma and Healthcare Sector Report 2018/2019 - Page 1
Chile Pharma and Healthcare Sector Report 2018/2019 EMIS Insights Industry Reports

In 2012-2017 Chile’s total health expenditure rose at a CAGR of 11.6%, driven by a solid increase of government spending on healthcare. In 2017, Chile allocated 8.1% of its GDP on healthcare, a figure that is bound to grow in the short term. ...

View more details
USD 495 Date: July 2018 Language: English
Format: PDF
Add to basket
Brazil Pharma & Healthcare Sector Report 2017/2021 - Page 1
Brazil Pharma & Healthcare Sector Report 2017/2021 EMIS Insights Industry Reports

Brazil is the eighth-largest pharmaceutical market in the world. In 2016, the retail drug market, based on ex-factory prices, rose by 15.5% y/y to BRL 87.2bn, supported by upward price dynamics and steady demand for innovative patented drugs. In ...

View more details
USD 995 Date: November 2017 Language: English
Format: PDF
Add to basket
Chile Healthcare and Pharmaceuticals Sector Report 2016/2017 - Page 1
Chile Healthcare and Pharmaceuticals Sector Report 2016/2017 EMIS Insights Industry Reports

In 2015, Chile was the sixth largest pharmaceutical market in Latin America in terms of sales volume, with 278mn units sold, and the seventh biggest in terms of sales value, with USD 1.53bn, based on ex-factory prices (USD 2.32bn, based on retail ...

View more details
USD 495 Date: January 2017 Language: English
Format: PDF
Add to basket